Session 2 of IASNM Radiant Flashpoints Educational Web-Series.
Speaker: David L. Bushnell, MD,
Professor of Radiology, Division of Nuclear Medicine,
University of Iowa Hospitals & Clinics
Chief, Diagnostic Imaging Services,
Iowa City VA Medical Center
Learning Objectives:
- Discuss the current updates on targeted radiomoleclar therapy in the US.
- Review the development of Peptide Receptor Radionuclide Therapy (PRRT).
- Evaluate the current state of PRRT in Neuroendocrine Tumors (NETs) in the US and future direction/implications.